verekitug — Topline data
H2 2027
Data from the study are expected in the second half of 2027.Source filing
UPB biotech catalysts & pipeline
UPSTREAM BIO INC · Data as of 2026-09-08
Upcoming catalysts
verekitug — NDA/BLA submission
2030
With supportive Phase 3 results, the Company expects to submit a Biologics License Application (BLA) to the FDA for both indications, which could enable potential launch as early as 2030.Source filing